|Bid||0.1400 x N/A|
|Ask||0.1700 x N/A|
|Day's Range||0.1350 - 0.1750|
|52 Week Range||0.0400 - 0.1900|
|Beta (5Y Monthly)||2.57|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Toronto, Ontario--(Newsfile Corp. - August 24, 2020) - U3O8 Corp. (TSXV: UWE.H), ("U3O8" or the "Company") announces that it has issued an aggregate total of 860,000 stock options to board members, management and consultants. The stock options have a five-year term and an exercise price of $0.12, corresponding to the closing price of the Company's stock on the NEX platform of the TSX Venture Exchange on August 21, 2020. These options comply with the ...
Toronto, Ontario--(Newsfile Corp. - August 10, 2020) - U3O8 Corp. (NEX: UWE.H), ("U3O8" or the "Company") is pleased to announce that its shareholders have approved all of the resolutions put before them at the Company's Annual General Meeting held in Toronto on Friday, August 7, 2020. Shareholders approved the financial statements for the year-ended December 31, 2019 and the report of the auditors thereon, the appointment of auditors, election of directors and the ...
U3O8 Corp. (NEX: UWE.H), (“U3O8” or the “Company”) reports that, further to the press release dated March 30, 2020, announcing that the Company would not be proceeding with the reverse takeover described in its March 2, 2020 press release, the Company’s submission to TSX Venture Exchange for the lifting of the halt on trading of the Company’s shares, has been accepted. Subject to final regulatory approval, trading of the Company’s common shares will resume on the NEX on opening of the market today, April 27, 2020. Company will continue to evaluate acquisition opportunities and other business opportunities that may become available to it in the context of the market, and of a strengthening uranium price, with a view to completing a reactivation transaction in accordance with the policies of the TSX Venture Exchange.